Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

NXEN

Nexien BioPharma (QB) (NXEN)

Nexien BioPharma Inc (QB)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:NXEN
DataHoraFonteTítuloCódigoCompanhia
15/05/202407:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NXENNexien BioPharma Inc (QB)
14/02/202408:04Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:NXENNexien BioPharma Inc (QB)
02/11/202317:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
28/09/202307:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:NXENNexien BioPharma Inc (QB)
15/05/202316:35Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:NXENNexien BioPharma Inc (QB)
19/04/202319:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
08/02/202308:18Edgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
21/01/202215:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NXENNexien BioPharma Inc (QB)
12/10/202107:16Edgar (US Regulatory)Annual Report (10-k)USOTC:NXENNexien BioPharma Inc (QB)
28/09/202107:05Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:NXENNexien BioPharma Inc (QB)
25/08/202018:20Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:NXENNexien BioPharma Inc (QB)
02/05/201915:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:NXENNexien BioPharma Inc (QB)
02/05/201907:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:NXENNexien BioPharma Inc (QB)
08/03/201911:37Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:NXENNexien BioPharma Inc (QB)
28/06/201807:09Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:NXENNexien BioPharma Inc (QB)
19/06/201815:56Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:NXENNexien BioPharma Inc (QB)
07/06/201807:20Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:NXENNexien BioPharma Inc (QB)
05/02/201812:36InvestorsHub NewsWireIntiva BioPharma Comments on Attorney General Jeff Sessions' Actions on January 4th that Affect State-Licensed Cannabis Busin...USOTC:NXENNexien BioPharma Inc (QB)
26/10/201716:04Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:NXENNexien BioPharma Inc (QB)
18/10/201714:56Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:NXENNexien BioPharma Inc (QB)
06/09/201613:30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:NXENNexien BioPharma Inc (QB)
 Apresentando as notícias mais relevantes sobre:USOTC:NXEN